The End or a New Era of Development of SARS-CoV-2 Virus: Genetic Variants Responsible for Severe COVID-19 and Clinical Efficacy of the Most Commonly Used Vaccines in Clinical Practice

Although the chief of the World Health Organization (WHO) has declared the end of the coronavirus disease 2019 (COVID-19) as a global health emergency, the disease is still a global threat. To be able to manage such pandemics in the future, it is necessary to develop proper strategies and opportunit...

Descripción completa

Detalles Bibliográficos
Autores principales: Miteva, Dimitrina, Kitanova, Meglena, Batselova, Hristiana, Lazova, Snezhina, Chervenkov, Lyubomir, Peshevska-Sekulovska, Monika, Sekulovski, Metodija, Gulinac, Milena, Vasilev, Georgi V., Tomov, Luchesar, Velikova, Tsvetelina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385722/
https://www.ncbi.nlm.nih.gov/pubmed/37514997
http://dx.doi.org/10.3390/vaccines11071181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385722/
https://www.ncbi.nlm.nih.gov/pubmed/37514997
http://dx.doi.org/10.3390/vaccines11071181

Ejemplares similares